Intelligence Platform
Patents
Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8314239
Modulators of cystic fibrosis transmembrane conductance regulator
granted patentUS 8314141
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
granted patentUS 8314125
Bicyclic derivatives as modulators of ion channels
granted patentUS 8309587
Piperidine and piperazine phenyl sulphonamides as modulators of ion channels
granted patentUS 8309543
Compositions useful as inhibitors of voltage-gated sodium channels
granted patentUS 8304423
Modulators of muscarinic receptors
granted patentUS 8304414
Pyrazole compounds useful as protein kinase inhibitors
granted patentUS 8299099
Heteroaryl derivatives as CFTR modulators
granted patentUS 8293929
Processes and intermediates
granted patentUS 8288400
Compositions useful as inhibitors of protein kinases
granted patentUS 8288537
Caspase inhibitors and uses thereof
granted patentUS 8278297
Protein kinase inhibitors
granted patentUS 8278306
C-met protein kinase inhibitors
granted patentUS 8273896
Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides
granted patentUS 8268999
Tri-cyclic pyrazolopyridine kinase inhibitors
granted patentUS 8268873
Inhibitors of IMPDH enzyme
granted patentUS 8269013
Substituted pyrazole inhibitors of c-Met protein kinase
granted patentUS 8268829
Substituted pyrimidines useful as protein kinase inhibitors
granted patentUS 8268811
Thiazoles and pyrazoles useful as kinase inhibitors
granted patentUS 8268818
Inhibitors of C-MET and uses thereof
granted patentUS 8269026
Lupane derivatives useful for treating HIV
granted patentUS 8269012
Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase
granted patentUS 8263632
Aminopyridine derivatives having Aurora A selective inhibitory action
granted patentUS 8263777
Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase
granted